510(k) Report

FDA product code · Clinical toxicology

Test System, For Drugs Of Abuse

MGXClass IIIPMA required1 decision since 19941 recall

1 FDA decision since 1994. 1 recall names this code; it is not Class I.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, clinical toxicology panel

Twenty years of MGX at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · MGX

FDA has decided no MGX device since 2007.

Median 510(k) review, days · MGX

Too few MGX 510(k)s in any year since 2007 to give a median.

Recalls per year · MGX

1in 2014

2014: 1
2007high 1 (2014) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MGX

1in 2017

2008: 82009: 12010: 22013: 22014: 12017: 1
2007high 8 (2008) · low 0 (2007)2025

MAUDE reports naming product code MGX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—08
20090—01
20100—02
20110—00
20120—00
20130—02
20140—11
20150—00
20160—00
20170—01
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—
FIG. 1 — MGX by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in MGX? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report